Immunology
-
Proinflammatory Responses in SARS-CoV-2 and Soluble Spike Glycoprotein S1 Subunit Activated Human Macrophages
This article has 5 authors:Reviewed by ScreenIT
-
COVID- e Vax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19
This article has 55 authors:Reviewed by ScreenIT
-
Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques
This article has 19 authors:Reviewed by ScreenIT
-
NAMPT-derived NAD + fuels PARP1 to promote skin inflammation through parthanatos
This article has 18 authors:Reviewed by Review Commons
-
Immunogenicity and In vivo protection of a variant nanoparticle vaccine that confers broad protection against emerging SARS-CoV-2 variants
This article has 21 authors:Reviewed by ScreenIT
-
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
This article has 26 authors:Reviewed by ScreenIT
-
Neutralizing antibodies elicited by the Ad26.COV2.S COVID-19 vaccine show reduced activity against 501Y.V2 (B.1.351), despite protection against severe disease by this variant
This article has 15 authors:Reviewed by ScreenIT
-
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells
This article has 23 authors:Reviewed by ScreenIT
-
Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine
This article has 21 authors:Reviewed by ScreenIT
-
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins
This article has 11 authors:Reviewed by ScreenIT